New York, Feb 24, 2026, 18:00 EST — After-hours
UnitedHealth Group Incorporated dropped 2.6% to $273.95 in Tuesday’s after-hours session, deepening a two-day pullback that’s weighed on the Dow component, even as the wider market managed a rebound.
Timing’s key here. Investors are already maneuvering as they eye what the final 2027 Medicare Advantage reimbursement rates might mean for profits. The window for public comment on the U.S. government’s proposed payment update closes Wednesday, Feb. 25. (Centers for Medicare & Medicaid Services)
Managed-care stocks struggled in the regular session, with UnitedHealth off roughly 3%. Humana and Elevance dropped as well, and CVS Health finished lower—even as both the S&P 500 and Dow posted gains. (MarketWatch)
UnitedHealth closed out Tuesday at $273.95, down from $282.34 at Monday’s finish. Shares have fallen roughly 5.5% across those two sessions, pricing data show. (StockAnalysis)
Medicare Advantage, the government-backed but privately managed take on Medicare, depends on federal payments to set the stage for both benefits and potential insurer profits. Payment changes flow straight into the bids insurers submit for the upcoming year’s plans. (Reuters)
Tension has gripped the group since late January, following UnitedHealth’s 2026 forecast and a proposed 2027 Medicare Advantage rate hike that landed well below expectations. “It starts to bring in worries about 2027 earnings growth,” said James Harlow, senior vice president at Novare Capital Management back then. (Reuters)
Tens of billions vanished from U.S. health insurer valuations that day, as UnitedHealth found itself in the thick of a sharp selloff. (Reuters)
Concerns are mounting over the core health of the Medicare Advantage market. For 2026, enrollment growth is lagging behind trends seen in the past few years, and insurers have started retreating from certain segments they describe as money-losers, according to a Monday report from MarketWatch. (MarketWatch)
A lot remains up in the air. Analysts are watching not just the headline rate but also any tweaks to risk adjustment and star ratings, which could end up carrying significant weight. The government’s final update could ultimately hit harder or land lighter than the draft, all hinging on CMS’s decisions. (Forvis Mazars)
Late Tuesday, UnitedHealth’s investor relations page showed the stock hovering near $274. The shares trade on the New York Stock Exchange, ticker symbol UNH. (UnitedHealth Group)
Feb. 25 marks the comment cutoff for the 2027 Medicare Advantage draft. Traders have their eyes on that, and they’re also watching for the final rate announcement, which is set to land by April 6 at the latest — both dates flagged as the next big catalysts for the group. (Centers for Medicare & Medicaid Services)
